SNPMiner Trials by Shray Alag


SNPMiner Trials: Clinical Trial Report


Report for Clinical Trial NCT01730599

Developed by Shray Alag, 2019.
SNP Clinical Trial Gene

A Longitudinal 5 Years Follow up Study in Parkinson's Disease (PD) Patients Carriers of the LRRK2 Gene G2019S Mutation

This is a longitudinal study in patients with Parkinson's Disease (PD) carriers of a genetic mutation - substitution of gly with ser in position 2019 (G2019S) in the leucine-rich repeat kinase 2 (LRRK2) gene. The purpose of this study is to explore the association between genetic mutations in the known genes and their influence on disease manifestation over few years of follow up

NCT01730599 Parkinson's Disease
MeSH: Parkinson Disease

1 Interventions

Name: neurological exam

Description: motor and cognitive functions

Type: Other

PD patients


Primary Outcomes

Measure: change from baseline in updrs motor and total scores

Time: the participants will be followed for 5 years. the measurements will be taken evry 18 month.

Cohort


There is one SNP

SNPs


1 G2019S

A Longitudinal 5 Years Follow up Study in Parkinson's Disease (PD) Patients Carriers of the LRRK2 Gene G2019S Mutation. --- G2019S ---

A Longitudinal Study in Parkinson's Disease (PD) Patients This is a longitudinal study in patients with Parkinson's Disease (PD) carriers of a genetic mutation - substitution of gly with ser in position 2019 (G2019S) in the leucine-rich repeat kinase 2 (LRRK2) gene. --- G2019S ---



HPO Nodes